부산대학교 도서관

Adame-Garcia SR; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA. Electronic address: sendi.adame.garcia@gmail.com.; Hoang TS; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA.; Tien Vo PT; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA.; Burghi V; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA.; Cervantes-Villagrana RD; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA.; Orduña-Castillo LB; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA.; Ramms DJ; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA.; Trejo J; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA.; Gutkind JS; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, School of Medicine, University of California San Diego, La Jolla, California, USA. Electronic address: sgutkind@ucsd.edu.

Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE

Ramms, Dana J; Raimondi, Francesco; Arang, Nadia; Herberg, Friedrich W; Taylor, Susan S; Gutkind, J Silvio; Schulte, Gunnar

Pharmacological Reviews, vol 73, iss 4

Gallego RA; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Scales S; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Toledo C; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Auth M; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Bernier L; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Berry M; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Brun S; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Chung L; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Davis C; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Diehl W; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Dress K; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Eisele K; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Elleraas J; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Ewanicki J; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Fobian Y; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Greasley S; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Greenwald EC; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Johnson TW; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Khamphavong P; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Lafontaine J; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Li J; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Linton A; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Maestre M; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Miller N; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Murtaza A; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Patman RL; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Quinlan CL; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Ramms DJ; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Richardson P; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Sach N; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Salomon-Ferrer R; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Silva F; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Timofeevski S; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Tran P; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Tran-Dubé M; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Wang F; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Wang W; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Wythes M; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Yang S; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; Zou A; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; VanArsdale T; Oncology Research Unit, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.; McAlpine I; Oncology Medicinal Chemistry, Pfizer Worldwide Research and Development, 10770 Science Center Drive, La Jolla, California 92121, United States.

Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-4804 (Electronic) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE

Zheng F; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Kelly MR; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Ramms DJ; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, University of California San Diego, La Jolla, CA 92093, USA.; Heintschel ML; Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA.; Tao K; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.; Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, OR 97201, USA.; Tutuncuoglu B; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA.; Lee JJ; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Ono K; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Foussard H; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA.; Chen M; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Herrington KA; Department of Biochemistry and Biophysics Center for Advanced Light Microscopy at UCSF, University of California, San Francisco, CA 94158, USA.; Silva E; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Liu SN; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Chen J; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Churas C; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Wilson N; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Kratz A; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Pillich RT; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Patel DN; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Park J; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Kuenzi B; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Yu MK; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Licon K; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Pratt D; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Kreisberg JF; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Kim M; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA.; Swaney DL; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA.; Nan X; Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239, USA.; Center for Spatial Systems Biomedicine, Oregon Health and Science University, Portland, OR 97201, USA.; Knight Cancer Early Detection Advanced Research Center, Oregon Health and Science University, Portland, OR 97201, USA.; Fraley SI; Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA.; Gutkind JS; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Pharmacology, University of California San Diego, La Jolla, CA 92093, USA.; Krogan NJ; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California, San Francisco, CA 94158, USA.; J. David Gladstone Institutes, San Francisco, CA 94158, USA.; Quantitative Biosciences Institute, University of California, San Francisco, CA 94158, USA.; Ideker T; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA 92093, USA.; Cancer Cell Map Initiative (CCMI), La Jolla, CA, USA.; Moores Cancer Center, University of California San Diego, La Jolla, CA 92093, USA.; Department of Bioengineering, University of California San Diego, La Jolla, CA 92093, USA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Swaney DL; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Ramms DJ; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Department of Pharmacology, University of California San Diego, La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA.; Wang Z; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA.; Park J; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA.; Goto Y; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA.; Soucheray M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Bhola N; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Kim K; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Zheng F; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA.; Zeng Y; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; McGregor M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Herrington KA; Department of Biochemistry and Biophysics Center for Advanced Light Microscopy at UCSF, University of California San Francisco, San Francisco, CA, USA.; O'Keefe R; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Jin N; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; VanLandingham NK; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Foussard H; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Von Dollen J; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Bouhaddou M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Jimenez-Morales D; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Obernier K; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Kreisberg JF; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA.; Kim M; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Johnson DE; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Jura N; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Cardiovascular Research Institute, University of California San Francisco, San Francisco, CA, USA.; Grandis JR; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA, USA.; Gutkind JS; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Department of Pharmacology, University of California San Diego, La Jolla, CA.; Moores Cancer Center, University of California San Diego, La Jolla, CA.; Ideker T; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.; Division of Genetics, Department of Medicine, University of California San Diego, La Jolla, CA.; Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.; Department of Computer Science, University of California San Diego, La Jolla, CA, USA.; Krogan NJ; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; J. David Gladstone Institutes, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA.; The Cancer Cell Map Initiative, San Francisco and La Jolla, CA.

Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 0404511 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9203 (Electronic) Linking ISSN: 00368075 NLM ISO Abbreviation: Science Subsets: MEDLINE

Burghi V; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Paradis JS; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Officer A; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Adame-Garcia SR; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Wu X; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Matthees ESF; Institut für Molekulare Zellbiologie, CMB - Center for Molecular Biomedicine, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.; Barsi-Rhyne B; Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, California, USA.; Ramms DJ; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Clubb L; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Acosta M; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA.; Tamayo P; Moores Cancer Center, University of California San Diego, La Jolla, California, USA.; Bouvier M; Department of Biochemistry and Molecular Medicine, Institute for Research in Immunology and Cancer, Université de Montréal, Québec, Canada.; Inoue A; Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, Miyagi, Japan.; von Zastrow M; Department of Psychiatry and Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, California, USA.; Hoffmann C; Institut für Molekulare Zellbiologie, CMB - Center for Molecular Biomedicine, Universitätsklinikum Jena, Friedrich-Schiller-Universität Jena, Jena, Germany.; Gutkind JS; Moores Cancer Center, University of California San Diego, La Jolla, California, USA; Department of Pharmacology, University of California San Diego, La Jolla, California, USA. Electronic address: sgutkind@health.ucsd.edu.

Publisher: Elsevier Inc. on behalf of American Society for Biochemistry and Molecular Biology Country of Publication: United States NLM ID: 2985121R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1083-351X (Electronic) Linking ISSN: 00219258 NLM ISO Abbreviation: J Biol Chem Subsets: MEDLINE

Ruiz-Saenz A; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Departments of Cell Biology & Medical Oncology, Erasmus University Medical Center Rotterdam, Rotterdam, The Netherlands.; Atreya CE; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Wang C; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Breast Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.; Pan B; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Department of Breast Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.; Dreyer CA; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Brunen D; Division of Molecular Carcinogenesis and Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Prahallad A; Division of Molecular Carcinogenesis and Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Muñoz DP; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Ramms DJ; Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.; Burghi V; Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.; Spassov DS; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Faculty of Pharmacy, Medical University of Sofia, Sofia, Bulgaria.; Fewings E; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Institute for Computational Biomedicine, Heidelberg, Germany.; Hwang YC; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Cowdrey C; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Moelders C; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Schwarzer C; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Wolf DM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Hann B; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; VandenBerg SR; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Shokat K; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Moasser MM; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Bernards R; Division of Molecular Carcinogenesis and Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Gutkind JS; Department of Pharmacology, University of California, San Diego, La Jolla, CA, USA.; Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA.; van 't Veer LJ; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.; Coppé JP; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA. Jean-Philippe.Coppe@ucsf.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Gilardi M; Moores Cancer Center, University of California San Diego, La Jolla, California.; Salk Cancer Center, La Jolla, California.; Nomis Cancer Center for Immunology and Microbial Pathogenesis, La Jolla, California.; Saddawi-Konefka R; Moores Cancer Center, University of California San Diego, La Jolla, California.; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California San Diego, La Jolla, California.; Wu VH; Moores Cancer Center, University of California San Diego, La Jolla, California.; Department of Pharmacology, University of California San Diego, La Jolla, California.; Lopez-Ramirez MA; Department of Nanoengineering, University of California San Diego, La Jolla, California.; Wang Z; Moores Cancer Center, University of California San Diego, La Jolla, California.; Soto F; Department of Nanoengineering, University of California San Diego, La Jolla, California.; Ramms DJ; Moores Cancer Center, University of California San Diego, La Jolla, California.; Proietto M; Section of Cell and Developmental Biology, University of California San Diego, La Jolla, California.; Mikulski Z; Microscopy Core Facility, La Jolla Institute for Immunology, La Jolla, California.; Miki H; Center of Autoimmunity and Inflammation, La Jolla Institute for Immunology, La Jolla, California.; Sharabi A; Moores Cancer Center, University of California San Diego, La Jolla, California.; Department of Radiation Medicine and Applied Sciences, University of California San Diego, La Jolla, California.; Kupor D; Department of Nanoengineering, University of California San Diego, La Jolla, California.; Rueda R; Department of Nanoengineering, University of California San Diego, La Jolla, California.; Hollern DP; Salk Cancer Center, La Jolla, California.; Nomis Cancer Center for Immunology and Microbial Pathogenesis, La Jolla, California.; Wang J; Department of Nanoengineering, University of California San Diego, La Jolla, California.; Gutkind JS; Moores Cancer Center, University of California San Diego, La Jolla, California.; Department of Pharmacology, University of California San Diego, La Jolla, California.

Publisher: American Association for Cancer Research, Inc Country of Publication: United States NLM ID: 101132535 Publication Model: Print Cited Medium: Internet ISSN: 1538-8514 (Electronic) Linking ISSN: 15357163 NLM ISO Abbreviation: Mol Cancer Ther Subsets: MEDLINE